2014
Hormonal Therapy for Aggressive Angiomyxoma
Schwartz PE, Hui P, McCarthy S. Hormonal Therapy for Aggressive Angiomyxoma. Journal Of Lower Genital Tract Disease 2014, 18: e55-e61. PMID: 24402356, DOI: 10.1097/lgt.0b013e3182a22019.Peer-Reviewed Original ResearchConceptsHormonal therapyMenopausal statusAggressive angiomyxomaPatient's menopausal statusRecurrent aggressive angiomyxomaEstrogen receptorRecurrent diseaseLeuprolide acetateProgestin receptor contentInitial surgical resectionExtent of diseaseTreatment of patientsMonthly leuprolideAdjuvant therapyNeoadjuvant therapyPelvic recurrencePostmenopausal womenPremenopausal womenSurgical resectionDefinitive treatmentHormonal agentsReceptor contentSensitive tumorsAromatase inhibitorsProgestin receptors
2012
Demographics of uterine serous cancer (USC) patients: A single institutional experience.
de Leon M, Lu L, Hui P, Santin A, Rutherford T, Arin-Silasi D, Azodi M, Ratner E, Schwartz P. Demographics of uterine serous cancer (USC) patients: A single institutional experience. Journal Of Clinical Oncology 2012, 30: e15581-e15581. DOI: 10.1200/jco.2012.30.15_suppl.e15581.Peer-Reviewed Original ResearchPast medical historyUterine cancerUSC patientsSEER dataBreast cancerPrior historyLargest single-institution experienceCommon uterine cancerSerous cancer patientsSmall institutional seriesSingle institution experienceSingle institutional experienceForms of cancerOlder ptsPt ageDiabetic womenPostmenopausal womenFIGO stageInstitutional seriesOral contraceptivesMenopause statusCancer patientsDisease stageMedical historyEstrogen dependency